Neurolutions Revenue and Competitors
Estimated Revenue & Valuation
- Neurolutions's estimated annual revenue is currently $7.8M per year.
- Neurolutions's estimated revenue per employee is $204,763
Employee Data
- Neurolutions has 38 Employees.
- Neurolutions grew their employee count by 52% last year.
Neurolutions's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO and Board Director | Reveal Email/Phone |
2 | Chief Business Officer | Reveal Email/Phone |
3 | Senior Director Engineering | Reveal Email/Phone |
4 | Clinical Relations Manager | Reveal Email/Phone |
5 | Clinical Manager | Reveal Email/Phone |
6 | Engineering Specialist | Reveal Email/Phone |
7 | Quality Engineer & Systems Specialist | Reveal Email/Phone |
Neurolutions Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.3M | 79 | 20% | N/A | N/A |
#2 | $8.5M | 31 | 11% | N/A | N/A |
#3 | $4.5M | 13 | -13% | N/A | N/A |
#4 | $8M | 25 | -4% | N/A | N/A |
#5 | $5.3M | 16 | -6% | N/A | N/A |
#6 | $54.2M | 163 | -8% | N/A | N/A |
#7 | $12M | 55 | -17% | N/A | N/A |
#8 | $10M | 30 | -9% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 43 | -7% | N/A | N/A |
What Is Neurolutions?
IpsiHand is an investigational medical device that is not available for sale. The IpsiHand utilizes brain-computer interface technology to facilitate rehabilitation and improve the brain-hand connection. The device is designed for stroke patients who have lost movement in their arm and hand.
keywords:N/AN/A
Total Funding
38
Number of Employees
$7.8M
Revenue (est)
52%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Neurolutions News
2022-04-13 - 44 'breakthrough' medical devices that earned FDA approval
Neurolutions IpsiHand upper extremity rehabilitation system, manufactured by Neurolutions; Cognoa autism spectrum disorder diagnosis aid,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 38 | 15% | N/A |
#2 | $3.5M | 38 | 12% | N/A |
#3 | $7.8M | 38 | 41% | N/A |
#4 | $9.3M | 39 | 18% | N/A |
#5 | N/A | 40 | 38% | N/A |